Joseph W Rovig sold $1.2M of NOV
President - Energy Equipment at NOV Inc.. 73,256 shares at an average of $16.40, traded Nov 7, 2024, filed Nov 8, 2024.
Score components
- +20RolePresident
- +25Trade size$1.2M at market
- +10Share of holdings soldSold 28% of holdings
- +15Cluster5 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -7.7%, 3m -3.6%, 6m -22.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-123946, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 7, 2024 | SOpen-market sale Common Stock | -73,256 | $16.40 | $1.2M | 191,567 | Nov 8, 2024 |
Related signals
Other insiders at NOV Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | NOV Inc. | David D Harrison director | $29k 1,784 shares | -2% | |
| 58Moderate | NOV Inc. | Scott B. Livingston See Remarks | $485k 29,410 shares | -32% | |
| 53Moderate | NOV Inc. | Craig L. Weinstock Sr. VP. & Gen. Counsel | $502k 30,481 shares | -12% | |
| 60Notable | NOV Inc. | Christy Lynn Novak VP, Corp. Controller, CAO | $673k 40,953 shares | -37% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.